On August 25, 2011, Alcon Pharmaceuticals filed a lawsuit (complaint available here) relating to Apotex’s filing of an Abbreviated New Drug Application seeking approval to manufacture and sell a generic version of Patanase nasal spray. Alcon asserts that Apotex’s spray infringes United States Patent No. 7,977,376, which claims, among other things, a topically administrable, aqueous, nasal spray solution.
The case has been assigned to Judge Means.
Alcon is represented by Marshall Searcy, Jr. and Michael Anderson, both of Kelly Hart & Hallman LLP; and Bruce Genderson, Adam Perlman, Thomas Selby, Daniel Shanahan, Shelley Webb, Christopher Mandernach, and Sara Kaiser, all of Williams & Connolly LLP.